GFAP and Alzheimer disease: This suggests that pathological aging with brain-specific chronic IL-6 expression in GFAP-IL6 mice, might have detrimental effects on the septal ChAT+ cholinergic population compared to the effect of normal aging, and it might underlie the genesis of some neuropathological changes associated with age-related progressive neurodegenerative diseases like AD.